The Effect of Local Corticosteroid Injection in Carpal Tunnel Syndrome Patients With Type 2 Diabetes
NCT07433257
Summary
Our study was planned as a prospective observational study aiming to compare the post-intervention recovery process between patients with carpal tunnel syndrome (CTS) and diabetes mellitus and patients with idiopathic carpal tunnel syndrome without diabetes mellitus. Patients who presented to the Physical Medicine and Rehabilitation outpatient clinic with clinical symptoms consistent with carpal tunnel syndrome and who were diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological findings and who received corticosteroid + local anesthetic injection will be included in the study. Data from patients who meet the inclusion and exclusion criteria will be included in the study. Patients' demographic and clinical data will be recorded. Records will be taken before treatment and at 4 and 12 weeks after treatment.
Eligibility
Inclusion Criteria * Carpal Tunnel Syndrome with Type 2 Diabetes Mellitus Group (Group 1): * Age between 18 and 75 years * Presence of clinical symptoms compatible with carpal tunnel syndrome (e.g., pain, paresthesia, numbness) for at least 3 months * Patients diagnosed with mild-to-moderate carpal tunnel syndrome based on electrophysiological findings * Diagnosis of type 2 diabetes mellitus * Regulated blood glucose levels, defined as hemoglobin A1c (HbA1c) \< 7% * Idiopathic Carpal Tunnel Syndrome Group (Group 2): * Age between 18 and 75 years * Presence of clinical symptoms consistent with carpal tunnel syndrome (e.g., pain, paresthesia, numbness) for at least 3 months * Patients diagnosed with mild-to-moderate carpal tunnel syndrome based on electrophysiological findings * No diagnosis of diabetes mellitus Exclusion Criteria * Severe carpal tunnel syndrome based on electrophysiological findings * Presence of polyneuropathy, cervical radiculopathy, brachial plexopathy, or thoracic outlet syndrome * Uncontrolled blood glucose levels in the diabetic group (hemoglobin A1c ≥ 7%) * Presence of another systemic disease, other than diabetes mellitus, that may cause carpal tunnel syndrome * Presence of a rheumatological disease * History of wrist surgery * Less than 6 months since a local corticosteroid injection for carpal tunnel syndrome * Less than 3 months since completion of a physical therapy program for carpal tunnel syndrome * Infection at the intended injection site * Presence of malignancy * Pregnancy
Conditions3
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07433257